A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Hsia, M.D.
Pennington Biomedical Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Facility
Baton Rouge, Louisiana, United States
- Research Facility
Marrero, Louisiana, United States
- Research Facility
Cincinnati, Ohio, United States
- Research Facility
Charleston, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2016
- Primary completion
- 31 Oct 2016
- Completion
- 30 Nov 2016
- Last update posted
- 23 Aug 2022
- Registered enrollment
- 42
- Registry id
- NCT02714062
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.